Search results for " impairment"

showing 10 items of 422 documents

Immune Alterations in Frailty Syndrome and Cognitive Impairment.

2020

Aged 80 and overImmunity CellularFrailtybusiness.industryEndocrinology Diabetes and MetabolismFrail ElderlyFrailty syndromemedicine.diseaseImmune systemRisk FactorsImmunologyImmunology and AllergyMedicineHumansCognitive DysfunctionCognitive impairmentbusinessAgedEndocrine, metabolicimmune disorders drug targets
researchProduct

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease

2015

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the charac…

Aged 80 and overMaleMILD COGNITIVE IMPAIRMENTScience & TechnologyPREDICTIONGeneral Science & TechnologyNormal DistributionBrainModels TheoreticalDIAGNOSISSensitivity and SpecificityMultidisciplinary SciencesPETAlzheimer DiseaseFluorodeoxyglucose F18Positron-Emission TomographyMD MultidisciplinaryHumansScience & Technology - Other TopicsFemaleRadiopharmaceuticalsResearch ArticleAged
researchProduct

The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-an…

2022

The COVID-19 pandemic may have a disproportionate impact on people with dementia/mild cognitive impairment (MCI) due to isolation and loss of services. The aim of this systematic review was to investigate the effects of the COVID-19 lockdown on neuropsychiatric symptoms (NPS) in people living with dementia/MCI. Two authors searched major electronic databases from inception to June 2021 for observational studies investigating COVID-19 and NPS in people with dementia/MCI. Summary estimates of mean differences in NPS scores pre- versus post-COVID-19 were calculated using a random-effects model, weighting cases using inverse variance. Study quality and risk of bias were assessed by the Newcastl…

Aged 80 and overMalemild cognitive impairment neuropsychiatric symptomsCognitive Dysfunction/diagnosisDementia/psychologyCOVID-19Neuropsychological TestsPsychiatry and Mental healthmental disordersCommunicable Disease ControlCOVID-19 dementia mild cognitive impairment neuropsychiatric symptomsHumansCognitive DysfunctionDementiaFemaleGeriatrics and GerontologyGerontologyPandemicsCOVID-19/epidemiologydementiaAgedPsychogeriatrics : the official journal of the Japanese Psychogeriatric Society
researchProduct

A combined electrophysiological and morphological examination of episodic memory decline in amnestic mild cognitive impairment.

2013

Early stages of Alzheimer’s disease (AD) are characterized by neuropathological changes within the medial temporal lobe cortex (MTLC), which lead to characteristic impairments in episodic memory, i.e., amnestic mild cognitive impairment (aMCI). Here, we tested the neural correlates of this memory impairment using event-related potentials (ERPs) and voxel-based morphometry. Twenty-four participants were instructed to encode lists of words and were tested in a yes/no recognition memory task. The dual-process model of recognition memory dissociates between acontextual familiarity and recollection of contextual details. The early frontal ERP old/new-effect, which is thought to represent a neura…

AgingCognitive Neuroscienceevent-related potentialsrecognition memorybehavioral disciplines and activitieslcsh:RC321-571Event-related potentialMemory impairmentvoxel-based morphometryOriginal Research ArticleMedial Temporal Lobeslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryEpisodic memoryRecognition memoryfamiliarityRecallBrain morphometryevent-related potential (ERP)Voxel-based morphometrymedial temporal lobeVoxel Based MorphometryTemporal lobe/cortexPsychologyNeuroscienceCognitive psychologyNeuroscienceFrontiers in aging neuroscience
researchProduct

Multimorbidity increases the risk of dementia: a 15 year follow-up of the SHARE study.

2023

Abstract Aims the literature regarding the association between multimorbidity and dementia is still unclear. Therefore, we aimed to explore the potential association between multimorbidity at the baseline and the risk of future dementia in the SHARE (Survey of Health, Ageing and Retirement in Europe) study, a large European research survey, with a follow-up of 15 years. Methods in this longitudinal study, multimorbidity was defined as the presence of two or more chronic medical conditions, among 14 self-reported at the baseline evaluation. Incident dementia was ascertained using self-reported information. Cox regression analysis, adjusted for potential confounders, was run and hazard ratios…

AgingGeneral MedicineGeriatrics and GerontologyAgeing and Retirement in Europe (SHARE) study Parkinson cognitive impairment cohort: Survey of Health dementia diabetes multimorbidity older people risk factor stroke
researchProduct

Neurofisiología y envejecimiento. Concepto y bases fisiopatológicas del deterioro cognitivo

2016

Brain ageing is produced by various morphological, biochemical, metabolic and circulatory changes, which are reflected in functional changes, whose impact depends on the presence or absence of cognitive impairment. Because of brain plasticity, together with redundancy of the distinct cerebral circuits, age- related deterioration of the brain at various levels does not always translate into loss of brain function. However, when the damage exceeds certain thresholds, there is age-related cognitive impairment, which increases the risk of developing various neurodegenerative diseases such as Alzheimer disease. Genetics, together with lifestyle, diet, and environmental factors, etc, can trigger …

AgingMedicine (miscellaneous)medicine.disease030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineAgeing030220 oncology & carcinogenesisNeuroplasticitymedicineGeriatrics and GerontologyAlzheimer's diseasePsychologyCognitive impairmentNeuroscienceBrain functionRevista Española de Geriatría y Gerontología
researchProduct

Effect of COVID-19 quarantine on cognitive, functional and neuropsychiatric symptoms in patients with mild cognitive impairment and dementia.

2022

Abstract Background During the last two years, COVID-19 affected older people with dementia or mild cognitive impairment (MCI), but conflicting and sparse results are still present. The objective of this study was to investigate the frequency and type of changes in functional, cognitive and behavioral and psychological symptoms of dementia (BPSD), and caregiver’s stress during the period of quarantine in 2020 in patients affected by dementia/MCI living in Palermo, Sicily. Methods Outpatients affected by MCI/dementia were evaluated before and after COVID-19 quarantine. Functional status was investigated using basic and instrumental activities of daily living (ADL); cognitive performance with…

AgingMild cognitive impairmentCOVID-19Neuropsychiatric symptomsCognitionmental disordersActivities of Daily LivingQuarantineHumansCognitive DysfunctionDementiaFemaleGeriatrics and GerontologyAgedAging clinical and experimental research
researchProduct

Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment

2009

Alzheimer's disease (AD) is the most common type of dementia in the elderly. Products of oxidative and nitrosative stress (OS and NS, respectively) accumulate with aging, which is the main risk factor for AD. This provides the basis for the involvement of OS and NS in AD pathogenesis. OS and NS occur in biological systems due to the dysregulation of the redox balance, caused by a deficiency of antioxidants and/or the overproduction of free radicals. Free radical attack against lipids, proteins, sugars and nucleic acids leads to the formation of bioproducts whose detection in fluids and tissues represents the currently available method for assessing oxidative/nitrosative damage. Post-mortem …

AgingPathologymedicine.medical_specialtyFree RadicalsAlzheimer’s disease Mild cognitive impairment Free radicals Nitrosative stress Oxidative stressBioenergeticsDiseaseOxidative phosphorylationmedicine.disease_causeBiochemistryPathogenesisAlzheimer DiseaseHumansMedicineDementiaMolecular BiologyFree-radical theory of agingbusiness.industryMetabolismmedicine.diseaseOxidative StressNeurologyImmunologySettore MED/26 - NeurologiaCognition DisordersReactive Oxygen SpeciesbusinessBiomarkersOxidative stressBiotechnology
researchProduct

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid de…

2012

Alzheimer's disease (AD) is characterized by amyloid-beta deposition in amyloid plaques, neurofibrillary tangles, inflammation, neuronal loss, and cognitive deficits. Cannabinoids display neuromodulatory and neuroprotective effects and affect memory acquisition. Here, we studied the impact of cannabinoid receptor type 1 (CB1) deficiency on the development of AD pathology by breeding amyloid precursor protein (APP) Swedish mutant mice (APP23), an AD animal model, with CB1-deficient mice. In addition to the lower body weight of APP23/CB1(-/-) mice, most of these mice died at an age before typical AD-associated changes become apparent. The surviving mice showed a reduced amount of APP and its …

Agingmedicine.medical_specialtyPathologyCannabinoid receptormedicine.medical_treatmentMutantMice TransgenicInflammationDiseaseNeuroprotectionAmyloid beta-Protein PrecursorMiceReceptor Cannabinoid CB1Alzheimer DiseaseCell Line TumorInternal medicinemental disordersmedicineAmyloid precursor proteinAnimalsHumansMaze LearningCognitive impairmentAmyloid beta-Peptidesbiologybusiness.industryGeneral NeuroscienceBody WeightAge FactorsBrainPeptide FragmentsDisease Models AnimalEndocrinologyGene Expression RegulationMutationbiology.proteinlipids (amino acids peptides and proteins)MicrogliaNeurology (clinical)CannabinoidGeriatrics and Gerontologymedicine.symptomCognition DisordersbusinessDevelopmental BiologyNeurobiology of Aging
researchProduct

Poor vision accompanied with other sensory impairments as a predictor of falls in older women

2008

Objectives:we studied visual acuity (VA) and co-existing hearing impairment and poor standing balance as predictors of falls. Design: prospective study with 1-year follow-up. Setting: research laboratory and residential environment. Participants: 428 women aged 63‐76 years from the Finnish Twin Study on Aging. Measurements: participants were followed up for incidence of falls over 1 year. VA, hearing ability and standing balance were assessed at the baseline. The incidence rate ratios (IRR) for falls were computed using the negative binomial regression model. Results: during the follow-up, 47% of participants experienced a fall. After adjusting for age and interdependence of twin sisters, p…

Agingmedicine.medical_specialtyVisual acuityVisual impairmentVisual AcuityVision LowPoison controlEmmetropia03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationPredictive Value of TestsResidence CharacteristicsRisk FactorsInjury preventionHumansMedicine030212 general & internal medicineHearing LossProspective cohort studyPostural BalanceFinlandAgedBalance (ability)business.industryIncidenceGeneral MedicineMiddle AgedRegression AnalysisAccidental FallsFemaleGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesFall preventionAge and Ageing
researchProduct